drugset / Trial / NCT07549451
Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms
NaSingle-groupOpen-labelTreatment
Summary
To learn if imetelstat can help to control MDS/MPNs.
Timeline
- Start
- 2026-10-08
- Primary completion
- 2027-05-31
- Completion
- 2027-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imetelstat | Oligonucleotide (other) | — | Intravenous |